Inventor · disambiguated record
Frederick Dewey
Also filed as: DEWEY FREDERICK · DEWEY FREDERICK E
12 granted patents·9 pending applications·40 citations·filing 2012–2025
89Inventor score
Files withREGENERON PHARMA15METREA BIOSCIENCES INC2UNIV LELAND STANFORD JUNIOR2DEWEY FREDERICK1DEWEY FREDERICK E1
Top patents by PatentIndex Score
21 records- 0195US11180757B117β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Nov 23, 2021·3 cites·30 claims
- 0294US11702700B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2021·Granted Jul 18, 2023·4 cites·27 claims
- 0394US10787647B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Sep 29, 2020·10 cites·52 claims
- 0492US11753628B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2022·Granted Sep 12, 2023·1 cites·26 claims
- 0592US10961583B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2018·Granted Mar 30, 2021·9 cites·29 claims
- 0686US2024141305A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0784US12286677B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2023·Granted Apr 29, 2025·0 cites·14 claims
- 0884US11845963B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Dec 19, 2023·1 cites·12 claims
- 0984US11485958B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2020·Granted Nov 1, 2022·1 cites·40 claims
- 1080US2023031669A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1178US11708415B2Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1REGENERON PHARMA·Filed 2019·Granted Jul 25, 2023·1 cites·18 claims
- 1277US10127346B2Systems and methods for interpreting a human genome using a synthetic reference sequenceDEWEY FREDERICK·Filed 2012·Granted Nov 13, 2018·9 cites·7 claims
- 1376US2025333737A117ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOFREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1474US2025305050A1Inhibition Of HSD17B13 In The Treatment Of Liver Disease In Patients Expressing The PNPLA3 I148M VariationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1573US10347359B2Method and system for network modeling to enlarge the search space of candidate genes for diseasesDEWEY FREDERICK E·Filed 2012·Granted Jul 9, 2019·1 cites·21 claims
- 1670US12359201B217ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jul 15, 2025·0 cites·39 claims
- 1770US2023374145A1Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL1REGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1864US2020251178A1Method and System for Identifying Clinical Phenotypes in Whole Genome DNA Sequence DataUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 1949US2025092014A1Compounds and methods of activating lipoprotein lipaseMETREA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2046US2023339871A1Compounds and methods of modulating 17b-hydroxysteroid dehydrogenase type 13METREA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2145US2015261913A1Method and System for Identifying Clinical Phenotypes in Whole Genome DNA Sequence DataUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederick Dewey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →